Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse - Scorecard - MDSpire

Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse

  • By

  • Jingyi Ma

  • Haoyu Li

  • Xueqi Yang

  • Yuzhe Cheng

  • Bingran Qi

  • Siyu Kang

  • He Qi

  • Ruiqun Qi

  • Jun Niu

  • May 15, 2026

  • 0 min

Share

Clinical Scorecard: Psoriasis: Understanding Its Role as a Systemic Inflammatory Disorder Through an Immune Set-Point Perspective on Comorbidities and Relapses

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals with psoriasis, particularly those with multi-organ involvement and comorbidities, emphasizing systemic implications.
Care Setting

Key Highlights

  • Add highlight: 'Metabolic reprogramming plays a crucial role in systemic inflammation associated with psoriasis.'

Guideline-Based Recommendations

Diagnosis

  • Evaluate systemic inflammatory markers in addition to cutaneous symptoms, including specific tests.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Consider both adaptive and innate immune pathways in treatment approaches, including specific therapies.

        Clinical Best Practices

        • Incorporate a holistic approach to manage both skin and systemic symptoms, emphasizing interdisciplinary collaboration.

        Related Resources & Content

        Original Source(s)

        Related Content